On October 18, 2021, Hudson Executive Capital LP announced that it has had and may continue to have discussions with Akoya Biosciences, Inc.?s management and board of directors to discuss the Company?s business, strategies and corporate governance. Hudson Executive Capital stated that it has found its conversations to date with management and the Board to be constructive. Hudson Executive Capital added that it may seek to have additional conversations with the management, the Board, stockholders of the Company and other persons to discuss the Company?s business, strategies, corporate governance, board composition and other matters related to the Company.